Multiplexed Diagnostics Market Expected to Reach USD 9.8 Billion Globally in 2019: Transparency Market Research

 Multiplexed Diagnostics Market Expected to Reach USD 9.8 Billion Globally in
                      2019: Transparency Market Research

  PR Newswire

  ALBANY, New York, March 12, 2014

ALBANY, New York, March 12, 2014 /PRNewswire/ --

According to a new market report published by Transparency Market Research "
Multiplexed Diagnostics Market (Technologies: Very High, High, Medium, Low
Density Multiplexed Assays& Next-Generation Sequencing; Applications:
Infectious Disease Diagnosis, Oncology, Autoimmune Diseases, Cardiac,
Allergies and Others)  -  Global Industry Analysis, Size, Sha re, Growth,
Trends and Forecast, 2013  -  2019 " , the global multiplexed diagnostics
market was valued at USD 2.8 billion in 2012 and is expected to grow at a CAGR
of 19.4%from 2013 to 2019, to reach an estimated value of USD 9.8 billion in

Browse Global Multiplexed Diagnostics  Market  Report with Full TOC at

Multiplexed diagnostics market is one of the fastest growing segmentsin the
diagnostics market. Factors such as increasing demand for rapid diagnostic
tools that can simultaneously screen multiple analytes in a single cycle of
the assay, high prevalence of infectious diseases and cardiac
diseasesworldwide and inability of conventional diagnostic tools to give
accurate and reliable results in lesser turnaround timewill have a tremendous
impact on the growth of the multiplexed diagnostics industry.

The global multiplexed diagnostics market is segmented on the basis of types
of technology, application area and geography. Based on this, the multiplexed
diagnostics market is classified into very high density multiplexed assays,
high density multiplexed assays, medium density multiplexed assays, low
density multiplexed assays and next-generation sequencing. In addition, this
market is also segmented on the basis of applicationssuch as infectious
disease diagnosis, oncology, autoimmune diseases, cardiac, allergies and
others. Next-generation sequencing is rapidly replacing other technologies
available in the multiplexed diagnostics market due to its capability of
screening analytes ranging from low to high density using same instrument at a
much cheaper cost. Furthermore, it is expected that the global market for
next-generation sequencing will reach USD 1.96 billion in 2019 growing at a
CAGR of 39.1%from 2013 to 2019.

The North American region currently leads the multiplexed diagnostics market
due to advantage of the early launch of ground-breakingtechnologies in this
region.Factors that currently drive the growthof the North American
multiplexed diagnostics market include existence of supportive economic base
particularly in terms of high disposable income, significant awareness about
available multiplexed diagnostic technologies and better adoption rate.
However,countries in the Asia-Pacificregion such as Japan, China and India are
reported to be emerging markets with development of healthcare infrastructure,
rapidly growing medical tourism industry and high prevalence of infectious
diseases and aging of population leading to rise in the incidence of cardiac
diseases and rapidly increasing healthcare awareness. Furthermore, apart from
Argentina, Mexico and Brazil, Egypt and African countries are some of the
lucrative markets for multiplexed diagnostics in the Rest of the World.

The global multiplexed diagnostics market has a limited number of market
players thus resulting in market consolidation and high competitive rivalry.
Some of the key participants operating in this market includeAffymetrix,
Agilent Technologies, Gen-Probe, Inc., bioMerieux, Life Technologies, Luminex
Corporation and Illumina, Inc.

Related & Recently Published Reports by Transparency Market Research

  *Polypropylene Market :
  *Distribution Automation Market :
  *Construction Paints and Coatings Market :
  *Pharmacovigilance Market :
  *Construction Paints and Coatings Market :

The global multiplexed diagnosticsmarket is segmented as follows:

Multiplexed Diagnostics Market, by Technology

  *Very High Density Multiplexed Assays
  *Oligonucleotide Arrays
  *Phage Display
  *High Density Multiplexed Assays
  *Bacterial Artificial Chromosome Arrays
  *Protein Arrays
  *Medium Density Multiplexed Assays
  *Bead-based Arrays
  *Antibody Arrays
  *Reverse Arrays
  *Mass Spectroscopy
  *Low Density Multiplexed Arrays
  *Quantitative PCR Bead-based Assays
  *Microplate Assays
  *Next-Generation Sequencing

Browse Multiplexed Diagnostics  Market  Report at

Multiplexed Diagnostics Market, by Application

  *Infectious Disease Diagnosis
  *Autoimmune diseases

Multiplexed Diagnostics Market, by Geography

  *North America
  *Rest of the World (RoW)

Browse all Medical Devices Market Research Reports @

About Us

Transparency Market Research is a global market intelligence company,
providing global business information reports and services. Our exclusive
blend of quantitative forecasting and trends analysis provides forward-looking
insight for thousands of decision makers. We are privileged with highly
experienced team of Analysts, Researchers, and Consultants, who use
proprietary data sources and various tools and techniques to gather, and
analyze information.

Our data repository is continuously updated and revised by a team of research
experts, so that it always reflects the latest trends and information. With a
broad research and analysis capability, Transparency Market Research employs
rigorous primary and secondary research techniques in developing distinctive
data sets and research material for business reports.

Contact Sheela AK 90 Sate Street, Suite 700Albany, NY 12207 Tel:
+1-518-618-1030USA - Canada Toll Free: 866-552-3453 Email: Web: Blog: Blog:
Press spacebar to pause and continue. Press esc to stop.